Transforming powder dressing versus standard dressing for acute partial-thickness burns
Official title: Prospective Randomized Open Label Multicenter Phase IV Clinical Trial to Compare Transforming Powder Dressing (TPD) to Current Standard of Care (SOC) Dressing Therapies in Acute Partial Thickness Burn Wounds
Run by ULURU Inc. · NCT05424354 · Data updated 2026-11-12
This trial tests whether the Altrazeal transforming powder dressing helps adults with recent partial-thickness burns heal faster and with less pain than standard dressings.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | ULURU Inc. Industry-sponsored |
| Locations | 6 sites (Orange, California and 5 other locations) |
| Status | Recruiting |
| Started | May 26, 2022 |
| Main results expected | June 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT05424354 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 hospitalized with an acute (within 72 hours) partial-thickness burn covering less than 20% total body surface area, without infection, and able to attend scheduled follow-up visits are ideal candidates.
✕Probably not a fit
Patients with full-thickness or infected burns, electrical burns, heavily draining wounds, pregnant or breastfeeding individuals, those outside the 18–65 age range, or burns exceeding 20% TBSA are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, controlled post-marketing trial enrolls adults 18–65 hospitalized with an acute partial-thickness burn involving under 20% total body surface area. Participants are randomized 1:1 to receive either the Altrazeal transforming powder dressing or a typical standard-of-care burn dressing, with wound cleaning and debridement per usual burn care. Wounds are photographed, measured, and monitored for healing and pain across up to eight visits during hospitalization and up to 28 days after enrollment. A patient satisfaction survey about the dressing is completed when the wound heals or at the end of follow-up.
Why it matters
Potential benefit: If successful, this dressing could speed healing, reduce wound pain, and make dressing changes easier for people with partial-thickness burns.
How similar studies have gone: Some small clinical reports and post-marketing experience suggest transforming powder dressings can support healing in partial-thickness wounds, but few large randomized comparisons to standard burn dressings exist.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized patients who are receiving burn care; patients may be discharged when clinically stable and continue with outpatient treatment. * Men and women (women cannot be pregnant or breast feeding) ages 18-65 years old * Wounds must be partial thickness, involving up to 20% of the total body surface area. * Burn injury should be less than 72 hours old * Willing and able to comply with protocol mandated scheduled study visits/clinical evaluations. * Willing and able to provide written informed consent. Exclusion Criteria: * Known allergy to TPD or its components * Women who are pregnant, breast feeding, or plan to get pregnant during the study period. * Infected wounds * Presence of any full thickness (third degree) burns * Electrical burns * Heavily draining burns due to underlying chronic lymphedema or other conditions * Concurrent clinical condition within the judgement of the clinician, pose a health risk to the patient, delay wound healing, or otherwise influence the outcome of the study. * History of poor wound healing and/or skin/immune system condition * Deemed by clinician not to be suitable * Unwilling or not able to provide consent or comply with protocol or required visits * Developmental disability/significant psychological disorder which can impair the subjects ability to provide informed consent, or participate in the study protocol * Active alcohol or substance abuse
Where it's running
-
University of California-Irvine
Orange, California, United States Recruiting -
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States Recruiting -
Jackson Memorial Hospital UM/JMH Burn Center
Miami, Florida, United States Recruiting -
University of Louisville Health
Louisville, Kentucky, United States Recruiting -
Westchester Medical Center
Valhalla, New York, United States Recruiting -
University of Texas SW (Parkland)
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Jonathan Saxe, MD — ULURU Inc.
- Study coordinator: Vai Shah
- Email: vshah@uluruinc.com
- Phone: 2149055145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of In-Hospital Death in Severe Abdominal Injury
This study will follow adults with severe abdominal trauma at a large Egyptian hospital to see which factors best predict in-hospital death.
-
Humidification methods in trauma ICU patients on mechanical ventilation
This study tests whether active heated humidifiers or passive heat-and-moisture exchangers work better in trauma ICU patients who need long-term mechanical ventilation.
-
Food Is Medicine post-operative meal delivery for orthopaedic trauma patients
This project will try whether delivering medically tailored meals and shakes for 12 days after surgery helps orthopaedic trauma patients recover better and improve metabolic lab markers.
-
WounDx device to help guide delayed closure of large traumatic limb wounds
This pilot tests whether the WounDx device can help surgeons decide when delayed closure will successfully heal large traumatic extremity wounds in adults.
-
Acupuncture for relieving symptoms of Gulf War Illness
This trial will test whether regular acupuncture can help veterans with Gulf War Illness feel less fatigued, have less pain, and improve physical functioning.
-
4-Aminopyridine to help heal second-degree skin burns
This trial will try 4-aminopyridine in adults with recent second-degree burns to see if it speeds healing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.